The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis

This study aims to evaluate the levels of serum endocan in children with juvenile idiopathic arthritis (JIA). Sixty-seven children with JIA (30 males, 37 females; mean age 10.4±4.9 years; range 2 to 18 years) and a sex- and age- matched healthy control group of 39 children (16 males, 23 females; mea...

Full description

Saved in:
Bibliographic Details
Published in:Archives of rheumatology 2018-06, Vol.33 (2), p.168-173
Main Authors: Yilmaz, Yasin, Berru Durmuş, Rana, Saraçoğlu, Başak, Şahin, Sezgin, Adrovic, Amra, Barut, Kenan, Özel Yildiz, Sevda, Kasapçopur, Özgür, Eker Ömeroğlu, Rukiye
Format: Article
Language:English
Subjects:
Analysis
Arthritis
Endothelium
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c543t-78a38e3ec784c9b1d42d485133ad50e70f6e48a4a2f713c2ff097f775631cd293
cites
container_end_page 173
container_issue 2
container_start_page 168
container_title Archives of rheumatology
container_volume 33
creator Yilmaz, Yasin
Berru Durmuş, Rana
Saraçoğlu, Başak
Şahin, Sezgin
Adrovic, Amra
Barut, Kenan
Özel Yildiz, Sevda
Kasapçopur, Özgür
Eker Ömeroğlu, Rukiye
description This study aims to evaluate the levels of serum endocan in children with juvenile idiopathic arthritis (JIA). Sixty-seven children with JIA (30 males, 37 females; mean age 10.4±4.9 years; range 2 to 18 years) and a sex- and age- matched healthy control group of 39 children (16 males, 23 females; mean age 9.3±4.1 years; range 1 to 17 years) were recruited. Patients with JIA were divided into two groups as the clinically active JIA group (n=27) and inactive JIA group (n=40). The median serum endocan level in patients with JIA was significantly higher than in the control group (633.75 ng/L vs. 379.76 ng/L, p
doi_str_mv 10.5606/ArchRheumatol.2018.6528
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6117134</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A598464207</galeid><sourcerecordid>A598464207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c543t-78a38e3ec784c9b1d42d485133ad50e70f6e48a4a2f713c2ff097f775631cd293</originalsourceid><addsrcrecordid>eNptkV9rFDEUxQdRbKn9ChoQfJs1mfydF2FYqq0sCNriY0gzN01kJlmS2YV-e7OsLV2Q-5AL-Z3Dvfc0zQeCV1xg8XnI1v_0sJvNkqZVh4laCd6pV815J4hqBcf4de0JUy3HTJw1l6X8wRgTJoXA9G1zRnGHJef9eXN36wENpUApM8QFJYd-Qd7N6CqOyZqINrCHqaAQ0dqHacwQ0e-wePR9t4cYJkA3Y0hbs_hg0ZAXn8MSyrvmjTNTgct_70Vz9_Xqdn3dbn58u1kPm9ZyRpdWKkMVULBSMdvfk5F1I1OcUGpGjkFiJ4Apw0znJKG2cw730knJBSV27Hp60Xw5-m539zOMtm6QzaS3OcwmP-pkgj79icHrh7TXgpDqyKrBx6PBg5lAh-hSxewcitUD7xUTrB6qUqv_ULVGmINNEVw9xKng0wuBBzMtvqRpt4QUyykoj6DNqZQM7nl2gvUhbH0Stj6ErQ9hV-X7l6s_656ipX8BcUOoeg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis</title><source>PubMed (Medline)</source><creator>Yilmaz, Yasin ; Berru Durmuş, Rana ; Saraçoğlu, Başak ; Şahin, Sezgin ; Adrovic, Amra ; Barut, Kenan ; Özel Yildiz, Sevda ; Kasapçopur, Özgür ; Eker Ömeroğlu, Rukiye</creator><creatorcontrib>Yilmaz, Yasin ; Berru Durmuş, Rana ; Saraçoğlu, Başak ; Şahin, Sezgin ; Adrovic, Amra ; Barut, Kenan ; Özel Yildiz, Sevda ; Kasapçopur, Özgür ; Eker Ömeroğlu, Rukiye</creatorcontrib><description>This study aims to evaluate the levels of serum endocan in children with juvenile idiopathic arthritis (JIA). Sixty-seven children with JIA (30 males, 37 females; mean age 10.4±4.9 years; range 2 to 18 years) and a sex- and age- matched healthy control group of 39 children (16 males, 23 females; mean age 9.3±4.1 years; range 1 to 17 years) were recruited. Patients with JIA were divided into two groups as the clinically active JIA group (n=27) and inactive JIA group (n=40). The median serum endocan level in patients with JIA was significantly higher than in the control group (633.75 ng/L vs. 379.76 ng/L, p&lt;0.01). Comparison between patients with active JIA and inactive JIA was not significant in terms of endocan levels (618.70 ng/L vs. 687.36 ng/L, p=0.34). There was a weak negative correlation between Childhood Health Assessment Questionnaire scores of patients with JIA and serum endocan levels. The high level of serum endocan highlighted the endothelial damage in patients with JIA.</description><identifier>ISSN: 2148-5046</identifier><identifier>EISSN: 2618-6500</identifier><identifier>DOI: 10.5606/ArchRheumatol.2018.6528</identifier><identifier>PMID: 30207559</identifier><language>eng</language><publisher>Turkey: Turkish League Against Rheumatism</publisher><subject>Analysis ; Arthritis ; Endothelium</subject><ispartof>Archives of rheumatology, 2018-06, Vol.33 (2), p.168-173</ispartof><rights>COPYRIGHT 2018 Turkish League Against Rheumatism</rights><rights>Copyright © 2018, Turkish League Against Rheumatism 2018 Turkish League Against Rheumatism</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c543t-78a38e3ec784c9b1d42d485133ad50e70f6e48a4a2f713c2ff097f775631cd293</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117134/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117134/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30207559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yilmaz, Yasin</creatorcontrib><creatorcontrib>Berru Durmuş, Rana</creatorcontrib><creatorcontrib>Saraçoğlu, Başak</creatorcontrib><creatorcontrib>Şahin, Sezgin</creatorcontrib><creatorcontrib>Adrovic, Amra</creatorcontrib><creatorcontrib>Barut, Kenan</creatorcontrib><creatorcontrib>Özel Yildiz, Sevda</creatorcontrib><creatorcontrib>Kasapçopur, Özgür</creatorcontrib><creatorcontrib>Eker Ömeroğlu, Rukiye</creatorcontrib><title>The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis</title><title>Archives of rheumatology</title><addtitle>Arch Rheumatol</addtitle><description>This study aims to evaluate the levels of serum endocan in children with juvenile idiopathic arthritis (JIA). Sixty-seven children with JIA (30 males, 37 females; mean age 10.4±4.9 years; range 2 to 18 years) and a sex- and age- matched healthy control group of 39 children (16 males, 23 females; mean age 9.3±4.1 years; range 1 to 17 years) were recruited. Patients with JIA were divided into two groups as the clinically active JIA group (n=27) and inactive JIA group (n=40). The median serum endocan level in patients with JIA was significantly higher than in the control group (633.75 ng/L vs. 379.76 ng/L, p&lt;0.01). Comparison between patients with active JIA and inactive JIA was not significant in terms of endocan levels (618.70 ng/L vs. 687.36 ng/L, p=0.34). There was a weak negative correlation between Childhood Health Assessment Questionnaire scores of patients with JIA and serum endocan levels. The high level of serum endocan highlighted the endothelial damage in patients with JIA.</description><subject>Analysis</subject><subject>Arthritis</subject><subject>Endothelium</subject><issn>2148-5046</issn><issn>2618-6500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNptkV9rFDEUxQdRbKn9ChoQfJs1mfydF2FYqq0sCNriY0gzN01kJlmS2YV-e7OsLV2Q-5AL-Z3Dvfc0zQeCV1xg8XnI1v_0sJvNkqZVh4laCd6pV815J4hqBcf4de0JUy3HTJw1l6X8wRgTJoXA9G1zRnGHJef9eXN36wENpUApM8QFJYd-Qd7N6CqOyZqINrCHqaAQ0dqHacwQ0e-wePR9t4cYJkA3Y0hbs_hg0ZAXn8MSyrvmjTNTgct_70Vz9_Xqdn3dbn58u1kPm9ZyRpdWKkMVULBSMdvfk5F1I1OcUGpGjkFiJ4Apw0znJKG2cw730knJBSV27Hp60Xw5-m539zOMtm6QzaS3OcwmP-pkgj79icHrh7TXgpDqyKrBx6PBg5lAh-hSxewcitUD7xUTrB6qUqv_ULVGmINNEVw9xKng0wuBBzMtvqRpt4QUyykoj6DNqZQM7nl2gvUhbH0Stj6ErQ9hV-X7l6s_656ipX8BcUOoeg</recordid><startdate>20180601</startdate><enddate>20180601</enddate><creator>Yilmaz, Yasin</creator><creator>Berru Durmuş, Rana</creator><creator>Saraçoğlu, Başak</creator><creator>Şahin, Sezgin</creator><creator>Adrovic, Amra</creator><creator>Barut, Kenan</creator><creator>Özel Yildiz, Sevda</creator><creator>Kasapçopur, Özgür</creator><creator>Eker Ömeroğlu, Rukiye</creator><general>Turkish League Against Rheumatism</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20180601</creationdate><title>The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis</title><author>Yilmaz, Yasin ; Berru Durmuş, Rana ; Saraçoğlu, Başak ; Şahin, Sezgin ; Adrovic, Amra ; Barut, Kenan ; Özel Yildiz, Sevda ; Kasapçopur, Özgür ; Eker Ömeroğlu, Rukiye</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c543t-78a38e3ec784c9b1d42d485133ad50e70f6e48a4a2f713c2ff097f775631cd293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Analysis</topic><topic>Arthritis</topic><topic>Endothelium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yilmaz, Yasin</creatorcontrib><creatorcontrib>Berru Durmuş, Rana</creatorcontrib><creatorcontrib>Saraçoğlu, Başak</creatorcontrib><creatorcontrib>Şahin, Sezgin</creatorcontrib><creatorcontrib>Adrovic, Amra</creatorcontrib><creatorcontrib>Barut, Kenan</creatorcontrib><creatorcontrib>Özel Yildiz, Sevda</creatorcontrib><creatorcontrib>Kasapçopur, Özgür</creatorcontrib><creatorcontrib>Eker Ömeroğlu, Rukiye</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Archives of rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yilmaz, Yasin</au><au>Berru Durmuş, Rana</au><au>Saraçoğlu, Başak</au><au>Şahin, Sezgin</au><au>Adrovic, Amra</au><au>Barut, Kenan</au><au>Özel Yildiz, Sevda</au><au>Kasapçopur, Özgür</au><au>Eker Ömeroğlu, Rukiye</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis</atitle><jtitle>Archives of rheumatology</jtitle><addtitle>Arch Rheumatol</addtitle><date>2018-06-01</date><risdate>2018</risdate><volume>33</volume><issue>2</issue><spage>168</spage><epage>173</epage><pages>168-173</pages><issn>2148-5046</issn><eissn>2618-6500</eissn><abstract>This study aims to evaluate the levels of serum endocan in children with juvenile idiopathic arthritis (JIA). Sixty-seven children with JIA (30 males, 37 females; mean age 10.4±4.9 years; range 2 to 18 years) and a sex- and age- matched healthy control group of 39 children (16 males, 23 females; mean age 9.3±4.1 years; range 1 to 17 years) were recruited. Patients with JIA were divided into two groups as the clinically active JIA group (n=27) and inactive JIA group (n=40). The median serum endocan level in patients with JIA was significantly higher than in the control group (633.75 ng/L vs. 379.76 ng/L, p&lt;0.01). Comparison between patients with active JIA and inactive JIA was not significant in terms of endocan levels (618.70 ng/L vs. 687.36 ng/L, p=0.34). There was a weak negative correlation between Childhood Health Assessment Questionnaire scores of patients with JIA and serum endocan levels. The high level of serum endocan highlighted the endothelial damage in patients with JIA.</abstract><cop>Turkey</cop><pub>Turkish League Against Rheumatism</pub><pmid>30207559</pmid><doi>10.5606/ArchRheumatol.2018.6528</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2148-5046
ispartof Archives of rheumatology, 2018-06, Vol.33 (2), p.168-173
issn 2148-5046
2618-6500
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6117134
source PubMed (Medline)
subjects Analysis
Arthritis
Endothelium
title The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-24T03%3A30%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Assessment%20of%20Serum%20Endocan%20Levels%20in%20Children%20With%20Juvenile%20Idiopathic%20Arthritis&rft.jtitle=Archives%20of%20rheumatology&rft.au=Yilmaz,%20Yasin&rft.date=2018-06-01&rft.volume=33&rft.issue=2&rft.spage=168&rft.epage=173&rft.pages=168-173&rft.issn=2148-5046&rft.eissn=2618-6500&rft_id=info:doi/10.5606/ArchRheumatol.2018.6528&rft_dat=%3Cgale_pubme%3EA598464207%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c543t-78a38e3ec784c9b1d42d485133ad50e70f6e48a4a2f713c2ff097f775631cd293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/30207559&rft_galeid=A598464207&rfr_iscdi=true